Matrix metalloproteinase-9 and stromal cell-derived factor-1 act synergistically to support migration of blood-borne monocytes into the injured spinal cord
about
A novel antagonist of p75NTR reduces peripheral expansion and CNS trafficking of pro-inflammatory monocytes and spares function after traumatic brain injury.A novel inhibitor of p75-neurotrophin receptor improves functional outcomes in two models of traumatic brain injury.Matrix Metalloproteinase 9 (MMP-9) Regulates Vein Wall Biomechanics in Murine Thrombus ResolutionEfficacy of a metalloproteinase inhibitor in spinal cord injured dogs.Sevoflurane preconditioning ameliorates neuronal deficits by inhibiting microglial MMP-9 expression after spinal cord ischemia/reperfusion in ratsCXCR3 antagonism of SDF-1(5-67) restores trabecular function and prevents retinal neurodegeneration in a rat model of ocular hypertension.Monocytes in sterile inflammation: recruitment and functional consequencesGenome-wide gene expression profiling of stress response in a spinal cord clip compression injury modelCXCR4 blockade attenuates hyperoxia-induced lung injury in neonatal ratsTetramethylpyrazine (TMP), an Active Ingredient of Chinese Herb Medicine Chuanxiong, Attenuates the Degeneration of Trabecular Meshwork through SDF-1/CXCR4 Axis.Exploratory study to suggest the possibility of MMP-8 and MMP-9 serum levels as early markers for remission after traumatic spinal cord injury.Hippocampal protection in mice with an attenuated inflammatory monocyte response to acute CNS picornavirus infectionSelective gelatinase inhibitor neuroprotective agents cross the blood-brain barrierInhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia.Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathyWater-soluble mmp-9 inhibitor prodrug generates active metabolites that cross the blood-brain barrierLectican proteoglycans, their cleaving metalloproteinases, and plasticity in the central nervous system extracellular microenvironment.Genetic and Pharmacological Inhibition of p38α Improves Locomotor Recovery after Spinal Cord Injury.Achieving CNS axon regeneration by manipulating convergent neuro-immune signaling.Concise review: the potential of stromal cell-derived factor 1 and its receptors to promote stem cell functions in spinal cord repair.Manipulating the extracellular matrix and its role in brain and spinal cord plasticity and repair.Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches.Crosstalk between astrocytic CXCL12 and microglial CXCR4 contributes to the development of neuropathic pain.The CXCR4/SDF1 axis improves muscle regeneration through MMP-10 activityControlled delivery of SDF-1α and IGF-1: CXCR4(+) cell recruitment and functional skeletal muscle recovery.Deficiency in matrix metalloproteinase-2 results in long-term vascular instability and regression in the injured mouse spinal cord.Role of Inflammation in Diabetic Retinopathy.Early Targeting of L-Selectin on Leukocytes Promotes Recovery after Spinal Cord Injury, Implicating Novel Mechanisms of PathogenesisLocal inhibition of matrix metalloproteinases reduced M2 macrophage activity and impeded recovery in spinal cord transected rats after treatment with fibroblast growth factor-1 and nerve grafts
P2860
Q27303179-2EDEFC43-D8C8-46FF-A5B7-8618AB07FC47Q27303512-0A9E5513-6E21-48E6-AD3F-4994E4B50A4DQ28548467-23528588-5E8D-4349-BB12-C960EAC8AA17Q33553427-128EE2C0-6340-404C-B0EA-E14A708A468AQ34169111-D97EA260-7D25-440A-A275-5EAA51A16051Q34295638-1D449CB5-F033-4E34-8831-221A9C99F32AQ34959012-410AC9F1-5431-41EA-88AC-A56C3A4CB289Q34975709-D90E0ECB-BC0A-49AA-8AF6-C4536CC9C9C9Q35690521-D71AE4EE-5932-47AE-8443-A372028A2731Q35746433-00CA1D45-93BF-4CBC-9878-31A0CDABE4EDQ36067668-DE6DC2EF-33DA-415F-9E18-E60FE27B6649Q36126949-FC4D6042-90B5-47EE-94D3-0629707C2471Q36326852-6566153E-5BFE-4067-850B-DADB351F4D8BQ36405496-7C760E2E-CD5D-4D0C-A41D-D0E346599499Q36468930-95D6627B-DD4D-4610-BD43-94A8EB02B536Q37113839-D3A8E648-8DCF-4B68-9D8C-56B89B8177A0Q37229269-84F9C2AC-5A33-4FB7-907B-8DA04CCA90EAQ37647554-353D61CF-BCB9-46D6-8CD9-225497A7634FQ38010639-42547364-A87B-4A72-B4B0-6D0AD811197DQ38063844-1D388751-6FD8-43F8-889E-AC91E1339436Q38179520-AF9A8940-97D9-4305-9FB2-E78680402E55Q38318458-C3766DA8-CD95-4E8B-8DC7-1D690C142A25Q38887975-07288148-7FF5-40B5-802F-9530A1E978BBQ40333177-25DA7D9C-A083-4353-A007-57852E192E18Q40654214-87751FD8-C04B-4903-B629-D47ED655E300Q41641630-A3985C5E-4953-485C-814F-2A20C6E43ED7Q52642996-25E90E06-3057-4005-A3CC-B5C0FE413547Q58693191-55E7892F-6904-4D1D-A2C8-53B55208B85EQ58805397-F8B6E593-ADAC-4B9C-970B-848656C155FA
P2860
Matrix metalloproteinase-9 and stromal cell-derived factor-1 act synergistically to support migration of blood-borne monocytes into the injured spinal cord
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Matrix metalloproteinase-9 and ...... s into the injured spinal cord
@ast
Matrix metalloproteinase-9 and ...... s into the injured spinal cord
@en
type
label
Matrix metalloproteinase-9 and ...... s into the injured spinal cord
@ast
Matrix metalloproteinase-9 and ...... s into the injured spinal cord
@en
prefLabel
Matrix metalloproteinase-9 and ...... s into the injured spinal cord
@ast
Matrix metalloproteinase-9 and ...... s into the injured spinal cord
@en
P2093
P2860
P1476
Matrix metalloproteinase-9 and ...... s into the injured spinal cord
@en
P2093
Alpa Trivedi
Haoqian Zhang
Jung-Uek Lee
Linda J Noble-Haeusslein
Marja Lohela
Sang Mi Lee
Thomas M Fandel
P2860
P304
15894-15903
P356
10.1523/JNEUROSCI.3943-11.2011
P407
P50
P577
2011-11-01T00:00:00Z